Late sodium current is a novel target for amiodarone: Studies in failing human myocardium
Late sodium current is a novel target for amiodarone: Studies in failing human myocardium
复制标题
DOI:
10.1006/jmcc.2001.1355
复制
发表时间:
2001-05-01
影响因子:
5
通讯作者:
Undrovinas, AI
中科院分区:
文献类型:
--
作者:
Maltsev, VA;Sabbah, HN;Undrovinas, AI
The authors recently reported the existence of a novel late Na+ current (I-Nal) in ventricular cardiomyocytes (VC) isolated from both normal and failing human hearts. Both in failing human and canine VC, partial block of I-Nal normalized action potential (AP) duration and abolished early after depolarizations (EADs). The most recent computer simulation studies indicate a significant contribution of the persistent Na+ current into the ion current balance on the plateau of VC Ar as well as its important rt,le in the dispersion of Ar duration across the ventricular wall. The data thus indicate a possibility for I-Nal to be a new therapeutic target. The present study tested a hypothesis that I-Nal could be a novel target fur amiodarone (AR;IIO). Midmyocardial VC isolated from left ventricle of explanted failing human hearts were measured by a whole-cell clamp. I-Nal was effectively blocked by AMIO in therapeutic concentrations. with IC50 being 6.7 +/- 1.1 muM (mean +/- S.E.M., n = 16 cells). At the same time. AMIO (5 muM) produced almost no effect on the transient Na+ current (IC50 = 87 +/- 28 muM, n = 8). AMIO significantly. shifted the steady-state inactivation (SSI) curl e of I-Nal towards more negative potentials and accelerated decay time course in a dose-dependent manner. At 5 muM AMIO shifted SSI by 21 +/- 3 mV (n = 7) and decreased the decay time constant from 0.67 +/- 0.05 s to 0.37 +/- 0.04 s (n = 5, P